CLYM
Climb Bio
$12.79
−$0.05 (−0.39%)Jul 27, 2026
Key metrics
The numbers that frame CLYM today
- Market cap
- $732.36M
- P/E (TTM)
- -13.9
- EV / FCF
- -13.5
- ROIC
- -36.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.36
- 52wk High
- $14.42
Growth
Revenue and earnings trend for CLYM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CLYM
Is Climb Bio a good buy?
Yes. Climb Bio has excellent momentum, and it outweighs the weak quality here. Growth looks excellent, which supports the long-term business case. We think Climb Bio is selling at a high price, which cuts against the buy case.
What is the market capitalization of CLYM?
Climb Bio's market capitalization is $732.36M.
What is the P/E ratio for CLYM stock?
Climb Bio's current P/E ratio is -13.9.
What is the 52-week high for CLYM stock?
The 52-week high for Climb Bio is $14.42. The current close of $12.79 is 11.3% below that high.
What is the 52-week low for CLYM stock?
The 52-week low for Climb Bio is $1.36. The current close of $12.79 is 840.4% above that low.
Does CLYM stock pay dividends?
Climb Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CLYM?
Climb Bio's Debt / Equity ratio is 0.